The Ensign Group Inc (ENSG) — the peer cohort

As of 2026-10-13 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

The Ensign Group Inc ranks 7 of 8 in its cohort on the Closelooknet composite (48/100) — the cohort is led by Halozyme Therapeutics Inc at 74/100.

Name	Composite	Momentum	Quality	Valuation	Signal	Off 52w high
ENSG The Ensign Group Inc	48	40	34	43	warn	20.5%
PACS PACS Group, Inc.	54	73	39	53	ok	10.3%
FMS Fresenius Medical Care Corporation	50	36	34	84	info	20.4%
RHC.AU Ramsay Health Care Ltd	45	91	22	52	ok	2%
HALO Halozyme Therapeutics Inc	74	93	94	48	ok	6.2%
DXCM DexCom Inc	66	85	80	35	bull	7.2%
ONC BeiGene, Ltd.	63	75	62	30	info	9.4%
MEDP Medpace Holdings Inc	63	83	74	28	ok	10%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-13

Quick answers

Who are The Ensign Group Inc's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: PACS Group, Inc. (PACS), Fresenius Medical Care Corporation (FMS), Ramsay Health Care Ltd (RHC.AU), Halozyme Therapeutics Inc (HALO), DexCom Inc (DXCM), BeiGene, Ltd. (ONC), Medpace Holdings Inc (MEDP).

How does ENSG score against its peers?

The Ensign Group Inc's composite reads 48/100, ranking 7 of 8 in its cohort as of 2026-10-13; the cohort's highest composite is Halozyme Therapeutics Inc at 74/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Medical Care Facilities, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.